Georgina N. Masoud
Cancer Research · 2015
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 15 citations into it
- Molecular Biology — 12 citations into it
- Physiology — 5 citations into it
Whom Georgina N. Masoud trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Georgina N. Masoud overall
Papers from Georgina N. Masoud's perspective
Ordered by how strongly the researchers Georgina N. Masoud trusts endorse each paper. Same corpus, a different order for every researcher.
- HIF-1 and human disease: one highly involved factor. (Genes & Development)
- HIF-1 and tumor progression: pathophysiology and therapeutics. (Trends in Molecular Medicine)
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF (Science)
- Hypoxia-inducible factor-1 (HIF-1). (Critical Care Medicine)
- Molecular mechanisms of blood vessel growth. (Cardiovascular Research)
- Hypoxia, HIF1 and glucose metabolism in the solid tumour (Nature Reviews. Cancer)
- HIF-1 and mechanisms of hypoxia sensing. (Current Opinion in Cell Biology)
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein (EMBO Journal)
Their papers
- HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) — 1,722 citations